Patheon and Softigel Launch P-Gels™ Softgel Service Offering

April 29, 2012

P-Gels give pharmaceutical companies a way to develop and manufacture prescription softgels with more flexibility and value.

Durham, NC (PRWEB) April 29, 2012

Two leaders in the pharmaceutical industry have joined forces to announce a new line of softgel development and manufacturing services, P-Gels, which is a partnership between Patheon, the world´s leading provider of contract development and manufacturing services, and Softigel, part of the Procaps Group, one of the world´s largest manufacturers of softgel products. Their combined softgel experience includes more than 528 products developed, 308 products manufactured, and 136 billion softgels produced.

The P-Gels team possesses world class softgel scientific expertise, breadth of formulation experience in BCS class I, II, III and IV compounds, deep knowledge of gelatin and non-gelatin-based techniques, as well as unique vertical supply-chain integration. P-Gels offers solutions for all product lifecycle phases, from early development to commercial manufacturing, in the same state-of-the-art facilities with equipment in GMP and non-GMP environments.

With over 30 years of experience in softgel manufacturing the team now designs and fabricates their own development scale and commercial equipment and tooling. Further enhancing efficiency, the group controls four gelatin manufacturing factories that are all certified to be BSE/TSE free. By integrating and controlling the entire process like no other provider, P-Gels will offer pharmaceutical companies shorter lead times, more manufacturing flexibility, freedom from intellectual property restrictions, and a broad range of dosage formats that are leading technologies:

  •     Unigel
  •     Softgels within softgels
  •     Tablets within softgels
  •     Beads within softgels
  •     Or combinations of liquids, tablets, softgels and/or beads in a single softgel capsule
  •     G-Tabs (gelatin coated tablets)
  •     VeggieGels

The P-Gels service offering is designed to give prescription pharmaceutical companies what they have been looking for — a high quality softgel solution at an exceptional value. With an available capacity of nine billion units, P-Gels will make a significant impact on the industry.

P-Gels offers more value, more flexibility, and more options than any other provider in the world.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/4/prweb9451793.htm

Source: prweb

comments powered by Disqus